Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19
Sugin Lal Jabaris S, V Ranju
Topics & Concepts
RoflumilastMedicineCytokine stormPathogenesisImmunologyCoronavirusRespiratory systemCOPDCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsCalcium signaling and nucleotide metabolism